Schedule 13D ownership disclosure

ITERUM THERAPEUTICS PLC SHS NEW

Security class unavailable · CUSIP: G6333L101

Event date: 2021-02-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-21-041808
Form type
SC 13D
Filer
Iterum Therapeutics plc
CIK
CIK 1659323
Filed
Feb 12, 2021
Reporting period
Feb 11, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub